. . . . . . . . . "\u7EB3\u7C73\u533B\u5B66"@zh . . . . . . . . "La nanomedicina es la aplicaci\u00F3n de la nanotecnolog\u00EDa en biomedicina, con el fin \u00FAltimo de mejorar la calidad de vida de los seres humanos, combatiendo las enfermedades de una forma innovadora.\u200B Un nan\u00F3metro (nm) es una millon\u00E9sima de un mil\u00EDmetro (10^-9 m). El aspecto m\u00E1s innovador de la nanomedicina es el empleo de nanomateriales para el diagn\u00F3stico y tratamiento de una patolog\u00EDa. La caracter\u00EDstica principal de un nanomaterial radica en que sus propiedades fisicoqu\u00EDmicas dependen del tama\u00F1o de dicho material.\u200B Mediante la modificaci\u00F3n del tama\u00F1o de dichos nanomateriales es posible obtener una se\u00F1al que nos indique la presencia o no de una enfermedad, entre otras muchas aplicaciones. El t\u00E9rmino nanomedicina se origin\u00F3 con las ideas de Eric Drexler acerca de la creaci\u00F3n de \"m\u00E1quinas\" complejas a partir de sus componentes at\u00F3micos. Dicho t\u00E9rmino ha sido definido de distintas maneras en la literatura, algunos de estos conceptos son lo suficientemente amplios como para incluir todas las \u00E1rea de la nanotecnolog\u00EDa m\u00E9dica, sin embargo la mayor\u00EDa se enfocan al control y manipulaci\u00F3n de procesos a nivel celular en la nanoescala, aplicado al diagn\u00F3stico y tratamiento. La investigaci\u00F3n en nanomedicina abarca desde el descubrimiento de nuevos nanomateriales con propiedades relevantes a la aplicaci\u00F3n cl\u00EDnica en distintas patolog\u00EDas. En este sentido el trabajo en nanomedicina abarca \u00E1reas cl\u00E1sicas como la qu\u00EDmica, la f\u00EDsica, la biolog\u00EDa y la ingenier\u00EDa. Las patolog\u00EDas en las que la nanomedicina est\u00E1 teniendo impacto son numerosas: desde c\u00E1ncer a enfermedades cardiovasculares, enfermedades raras y enfermedades infecciosas. En este \u00FAltimo caso se refleja claramente en el espectacular \u00E9xito de las vacunas basadas en ARN mensajero, las cuales no podr\u00EDan existir sin el uso de nanomateriales lip\u00EDdicos que protegen la mol\u00E9cula hasta que llegue a la c\u00E9lula. Este \u00E9xito tampoco debe ocultar lo que constituye el mayor cuello de botella de la nanomedicina: la dificultad de que nuevos desarrollos en el laboratorio alcancen al paciente. Por \u00E1reas de aplicaci\u00F3n las nanomedicinas pueden emplearse en tres campos principalmente: diagn\u00F3stico in vitro, diagn\u00F3stico in vivo y regeneraci\u00F3n de tejidos."@es . . . . . . "\u041D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0430"@ru . "21514"^^ . . "\u0637\u0628 \u0627\u0644\u0646\u0627\u0646\u0648"@ar . . . . . . . . . . . . . . . . "\uB098\uB178\uC758\uD559\uC740 \uB098\uB178\uAE30\uC220\uC744 \uC758\uD559\uC801\uC73C\uB85C \uC751\uC6A9\uD55C \uD559\uBB38\uC774\uB77C\uACE0 \uD560 \uC218 \uC788\uB2E4. \uC774\uB294 \uB098\uB178\uBB3C\uC9C8\uC744 \uC758\uD559\uC801\uC73C\uB85C \uC751\uC6A9\uD55C \uAC83\uC5D0\uC11C\uBD80\uD130 \uB098\uB178 \uC804\uC790 \uC0DD\uCCB4\uC13C\uC11C, \uBBF8\uB798 \uAC00\uB2A5\uD55C \uBD84\uC790 \uB098\uB178\uAE30\uC220\uC744 \uC751\uC6A9\uD55C \uAC83\uAE4C\uC9C0 \uD3EC\uD568\uD55C\uB2E4. \uD604\uC7AC \uC774\uC640 \uAD00\uB828\uD574\uC11C \uAC00\uC7A5 \uD070 \uBB38\uC81C\uC810\uC73C\uB85C \uC5EC\uACA8\uC9C0\uB294 \uAC83\uC740 \uB098\uB178\uB2E8\uC704\uC758 \uBB3C\uC9C8\uB4E4\uC774 \uD658\uACBD\uACFC \uC778\uCCB4\uC5D0 \uC720\uB3C5\uD55C \uC601\uD5A5\uC744 \uB07C\uCE60 \uC218 \uC788\uB2E4\uB294 \uAC83\uC774\uB2E4. \uC0DD\uBB3C \uBD84\uC790\uB098 \uAD6C\uC870\uB97C \uB098\uB178 \uBB3C\uC9C8\uACFC \uC811\uBAA9\uC2DC\uD0B4\uC73C\uB85C\uC368 \uC5EC\uB7EC \uB2E4\uC591\uD55C \uAE30\uB2A5\uB4E4\uC744 \uAC00\uC9C0\uAC8C \uD560 \uC218 \uC788\uB294\uB370, \uB098\uB178 \uBB3C\uC9C8\uB4E4\uC758 \uD06C\uAE30\uAC00 \uB300\uBD80\uBD84\uC758 \uC0DD\uBB3C\uD559\uC801\uC778 \uBD84\uC790\uB098 \uAD6C\uC870\uC758 \uD06C\uAE30\uC640 \uBE44\uC2B7\uD558\uAE30 \uB54C\uBB38\uC774\uB2E4. \uADF8\uB798\uC11C \uC774\uB294 \uCCB4\uB0B4, \uCCB4\uC678\uC758 \uC0DD\uBB3C\uC758\uD559 \uC5F0\uAD6C, \uC751\uC6A9\uC5D0 \uB9E4\uC6B0 \uC720\uC6A9\uD558\uB2E4. \uC9C0\uAE08\uAE4C\uC9C0\uB294 \uB098\uB178 \uBB3C\uC9C8\uB4E4\uC774 \uC0DD\uBB3C\uD559\uACFC \uACB0\uD569\uD574\uC11C \uC9C4\uB2E8 \uAE30\uAE30, \uC0DD\uCCB4 \uBD84\uC11D\uAE30\uAD6C, \uBB3C\uB9AC\uCE58\uB8CC \uC694\uBC95, \uC57D\uBB3C \uC804\uB2EC \uB9E4\uCCB4 \uB4F1\uC758 \uBC1C\uC804\uC774 \uC774\uB8E8\uC5B4\uC84C\uB2E4. \uB098\uB178\uBC14\uC774\uC624 \uAE30\uC220\uC758 \uAD81\uADF9\uC801\uC778 \uBAA9\uD45C \uC911 \uD558\uB098\uB85C \uB098\uB178 \uD06C\uAE30\uC758 \uB85C\uBD07\uC778 \uB098\uB178\uBD07\uC744 \uAC1C\uBC1C\uD558\uB294 \uAC83\uC774 \uC788\uB2E4. \uB098\uB178 \uD06C\uAE30\uC758 \uBC14\uC774\uB7EC\uC2A4\uAC19\uC774 \uC790\uC5F0\uC801\uC73C\uB85C \uCE58\uBA85\uC801\uC778 \uD53C\uD574\uB97C \uC77C\uC73C\uD0A4\uB294 \uAC83\uC744 \uBB3C\uB9AC\uCE58\uB294 \uBC29\uBC95\uC73C\uB85C \uC778\uACF5\uC758 \uB098\uB178\uAE30\uACC4\uB97C \uB9CC\uB4DC\uB294 \uAC83\uC774 \uAC00\uC7A5 \uD6A8\uACFC\uC801\uC774\uB77C\uB294 \uAC83\uC774 \uB098\uB178\uC758\uD559\uC758 \uAE30\uBCF8 \uC804\uC81C\uC774\uB2E4. \uB098\uB178\uBD07\uC758 \uB0B4\uBD80\uC5D0\uB294 \uBCD1\uC6D0\uADE0\uC744 \uCC3E\uC544\uC11C \uD30C\uAD34\uD558\uB3C4\uB85D \uD504\uB85C\uADF8\uB7A8\uB418\uC5B4 \uC788\uB294 \uB098\uB178\uCEF4\uD4E8\uD130\uAC00 \uB4E4\uC5B4 \uC788\uC73C\uBA70, \uBAA9\uD45C\uBB3C\uC758 \uBAA8\uC591\uC744 \uAC10\uC9C0\uD558\uACE0 \uC2DD\uBCC4\uD558\uB294 \uB098\uB178\uC13C\uC11C\uAC00 \uBD80\uCC29\uB418\uC5B4 \uC788\uB2E4. \uD608\uB958 \uC18D\uC5D0\uC11C \uC6C0\uC9C1\uC774\uB294 \uB098\uB178\uBD07\uC740 \uB098\uB178\uC13C\uC11C\uB85C\uBD80\uD130 \uC815\uBCF4\uB97C \uBC1B\uC544 \uB098\uB178\uCEF4\uD4E8\uD130\uC5D0 \uC800\uC7A5\uB41C \uBCD1\uC6D0\uADE0\uC758 \uC790\uB8CC\uC640 \uBE44\uAD50\uD55C \uB2E4\uC74C\uC5D0 \uBCD1\uC6D0\uADE0\uC73C\uB85C \uD310\uB2E8\uB418\uBA74 \uBC14\uB85C \uC57D\uBB3C\uC744 \uBC29\uCD9C\uD574\uC11C \uACA9\uBA78\uD55C\uB2E4. \uC774\uC640 \uAC19\uC740 \uBC29\uC2DD\uC73C\uB85C, \uB098\uB178\uBD07\uC740 \uC778\uCCB4 \uC548\uC73C\uB85C \uB4E4\uC5B4\uAC00\uC11C \uC190\uC0C1\uB41C \uC138\uD3EC\uB97C \uC218\uB9AC\uD558\uACE0, \uBC14\uC774\uB7EC\uC2A4\uB97C \uC81C\uAC70\uD558\uB294 \uB4F1\uC758 \uC5ED\uD560\uC744 \uC218\uD589\uD558\uB294 \uAC83\uC774\uB2E4. \uBFD0\uB9CC \uC544\uB2C8\uB77C, \uB1CC \uC548\uC5D0 \uB4E4\uC5B4\uAC00\uB294 \uB098\uB178\uBD07\uC740 \uB1CC\uC758 \uC218\uB9CE\uC740 \uC2E0\uACBD\uC138\uD3EC\uC640 \uC815\uBCF4\uB97C \uAD50\uD658\uD558\uBA70 \uC2E0\uACBD\uACC4\uC640 \uC0C1\uD638\uC791\uC6A9\uD558\uBA74\uC11C \uC778\uAC04\uC758 \uC9C0\uB2A5\uC744 \uD06C\uAC8C \uD5A5\uC0C1\uC2DC\uD0AC \uC218 \uC788\uB2E4. \uB098\uB178\uBD07\uC744 \uBE44\uB86F\uD574\uCE58\uB8CC\uD558\uACE0 \uC2E0\uCCB4\uC801 \uAE30\uB2A5\uC744 \uB354 \uB6F0\uC5B4\uB098\uAC8C \uB9CC\uB4E4\uC5B4 \uC904 \uC218 \uC788\uC73C\uBA70, \uB354 \uB098\uC544\uAC00 \uC815\uC2E0\uC801\uC778 \uBD80\uBD84\uAE4C\uC9C0 \uC774\uC810\uC744 \uAC00\uC838\uB2E4\uC904 \uAC83\uC774\uB2E4."@ko . . . "A Nanotecnologia \u00E9 definida como: \"Design intencional, caracteriza\u00E7\u00E3o, produ\u00E7\u00E3o e aplica\u00E7\u00E3o de materiais, estruturas, aparelhos e sistemas controlando seu tamanho e formato na escala nanom\u00E9trica (1 a 100 nm)\". Este conceito aplicado \u00E0 medicina \u00E9 a \u00E1rea de trabalho da nanomedicina. Nanomateriais possuem semelhan\u00E7a com componentes de atividade biol\u00F3gica, prote\u00EDnas, bact\u00E9rias, c\u00E9lulas defeituosas e mol\u00E9culas, pois todos est\u00E3o contidos na escala nanom\u00E9trica."@pt . "Nanomedicina"@es . . . . "Nanomedikuntza nanoteknologiaren zati bat da, gaixotasunak gorputzaren barnetik sendatzea ahalbidetzen duen maila zelular eta molekular batean. Medikuntzaren barnean dauden aurrerapenen artean arrakastatsuenetakoa da.Osasun eremuan nanoteknologia aplikatzea biziki baliagarria gerta daiteke, diagnostiko zehatzagoak egiteko edo terapia eraginkorragoak eragiteko, botika premiazkoa den toki zehatzera joan dadin (horrek, noski, alboko efektuak murriztu egingo lituzke) edo zelulekin komunikatzeko gauza liratekeen materialak sortzeko, ehunen birsorkuntza eragin dezaten, adibidez."@eu . "\u0397 \u03BD\u03B1\u03BD\u03BF\u03CA\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03B5\u03AF\u03BD\u03B1\u03B9 \u03B7 \u03B9\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03B5\u03C6\u03B1\u03C1\u03BC\u03BF\u03B3\u03AE \u03C4\u03B7\u03C2 \u03BD\u03B1\u03BD\u03BF\u03C4\u03B5\u03C7\u03BD\u03BF\u03BB\u03BF\u03B3\u03AF\u03B1\u03C2 . \u0397 \u03BD\u03B1\u03BD\u03BF\u03CA\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03B5\u03BA\u03C4\u03B5\u03AF\u03BD\u03B5\u03C4\u03B1\u03B9 \u03B1\u03C0\u03CC \u03C4\u03B9\u03C2 \u03B9\u03B1\u03C4\u03C1\u03B9\u03BA\u03AD\u03C2 \u03B5\u03C6\u03B1\u03C1\u03BC\u03BF\u03B3\u03AD\u03C2 \u03BD\u03B1\u03BD\u03BF\u03CB\u03BB\u03B9\u03BA\u03CE\u03BD \u03BA\u03B1\u03B9 \u03B2\u03B9\u03BF\u03BB\u03BF\u03B3\u03B9\u03BA\u03CE\u03BD \u03C3\u03C5\u03C3\u03BA\u03B5\u03C5\u03CE\u03BD, \u03AD\u03C9\u03C2 \u03C4\u03BF\u03C5\u03C2 \u03BD\u03B1\u03BD\u03BF\u03B7\u03BB\u03B5\u03BA\u03C4\u03C1\u03BF\u03BD\u03B9\u03BA\u03BF\u03CD\u03C2 \u03B2\u03B9\u03BF\u03B1\u03B9\u03C3\u03B8\u03B7\u03C4\u03AE\u03C1\u03B5\u03C2, \u03B1\u03BA\u03CC\u03BC\u03B7 \u03BA\u03B1\u03B9 \u03C0\u03B9\u03B8\u03B1\u03BD\u03AD\u03C2 \u03BC\u03B5\u03BB\u03BB\u03BF\u03BD\u03C4\u03B9\u03BA\u03AD\u03C2 \u03B5\u03C6\u03B1\u03C1\u03BC\u03BF\u03B3\u03AD\u03C2 \u03C4\u03B7\u03C2 \u03BC\u03BF\u03C1\u03B9\u03B1\u03BA\u03AE\u03C2 \u03BD\u03B1\u03BD\u03BF\u03C4\u03B5\u03C7\u03BD\u03BF\u03BB\u03BF\u03B3\u03AF\u03B1\u03C2, \u03CC\u03C0\u03C9\u03C2 \u03BF\u03B9 \u03B2\u03B9\u03BF\u03BB\u03BF\u03B3\u03B9\u03BA\u03AD\u03C2 \u03BC\u03B7\u03C7\u03B1\u03BD\u03AD\u03C2 . \u03A4\u03B1 \u03C4\u03C1\u03AD\u03C7\u03BF\u03BD\u03C4\u03B1 \u03C0\u03C1\u03BF\u03B2\u03BB\u03AE\u03BC\u03B1\u03C4\u03B1 \u03B3\u03B9\u03B1 \u03C4\u03B7 \u03BD\u03B1\u03BD\u03BF\u03CA\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03BF\u03C5\u03BD \u03C4\u03B7\u03BD \u03BA\u03B1\u03C4\u03B1\u03BD\u03CC\u03B7\u03C3\u03B7 \u03C4\u03C9\u03BD \u03B8\u03B5\u03BC\u03AC\u03C4\u03C9\u03BD \u03C0\u03BF\u03C5 \u03C3\u03C7\u03B5\u03C4\u03AF\u03B6\u03BF\u03BD\u03C4\u03B1\u03B9 \u03BC\u03B5 \u03C4\u03B7\u03BD \u03C4\u03BF\u03BE\u03B9\u03BA\u03CC\u03C4\u03B7\u03C4\u03B1 \u03BA\u03B1\u03B8\u03CE\u03C2 \u03BA\u03B1\u03B9 \u03C4\u03B9\u03C2 \u03C0\u03B5\u03C1\u03B9\u03B2\u03B1\u03BB\u03BB\u03BF\u03BD\u03C4\u03B9\u03BA\u03AD\u03C2 \u03B5\u03C0\u03B9\u03C0\u03C4\u03CE\u03C3\u03B5\u03B9\u03C2 \u03C4\u03C9\u03BD \u03C5\u03BB\u03B9\u03BA\u03CE\u03BD \u03BD\u03B1\u03BD\u03BF\u03BA\u03BB\u03AF\u03BC\u03B1\u03BA\u03B1\u03C2 (\u03C5\u03BB\u03B9\u03BA\u03CE\u03BD \u03C4\u03C9\u03BD \u03BF\u03C0\u03BF\u03AF\u03C9\u03BD \u03B7 \u03B4\u03BF\u03BC\u03AE \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C3\u03C4\u03B7\u03BD \u03BA\u03BB\u03AF\u03BC\u03B1\u03BA\u03B1 \u03C4\u03C9\u03BD \u03BD\u03B1\u03BD\u03BF\u03BC\u03AD\u03C4\u03C1\u03C9\u03BD, \u03B4\u03B7\u03BB\u03B1\u03B4\u03AE \u03B4\u03B9\u03C3\u03B5\u03BA\u03B1\u03C4\u03BF\u03BC\u03BC\u03C5\u03C1\u03B9\u03BF\u03C3\u03C4\u03AC \u03C4\u03BF\u03C5 \u03BC\u03AD\u03C4\u03C1\u03BF\u03C5 )."@el . . . "\u7EB3\u7C73\u533B\u5B66\u662F\u968F\u7740\u7EB3\u7C73\u751F\u7269\u533B\u836F\u53D1\u5C55\u8D77\u6765\u7528\u7EB3\u7C73\u6280\u672F\u89E3\u51B3\u533B\u5B66\u95EE\u9898\u7684\u5B66\u79D1\u3002 \u7EB3\u7C73\u6280\u672F\u548C\u6750\u6599\u7684\u53D1\u5C55\u5C06\u5C06\u7ED9\u533B\u5B66\u9886\u57DF\u5E26\u6765\u4E00\u573A\u6DF1\u523B\u7684\u9769\u547D\uFF0C\u4E3B\u8981\u5728\u5BF9\u4ED8\u764C\u75C7\u548C\u6CBB\u7597\u5FC3\u8840\u7BA1\u75BE\u75C5\u65B9\u9762\u6709\u91CD\u8981\u610F\u4E49\u3002 \u7EB3\u7C73\u6750\u6599\u5177\u6709\u4E0E\u4E00\u822C\u6750\u6599\u6240\u4E0D\u540C\u7684\u7269\u7406\u5316\u5B66\u6027\u80FD\u3002 \u7EB3\u7C73\u6280\u672F\u53EF\u80FD\u5C06\u5728\u4EE5\u4E0B\u65B9\u9762\u5BF9\u533B\u5B66\u4EA7\u751F\u8F83\u5927\u7684\u5F71\u54CD\uFF1A \n* \u4F7F\u8BCA\u65AD\u66F4\u7CBE\u786E\u5E94\u7528\u7EB3\u7C73\u6280\u672F\u53EF\u5C06\u5FAE\u578B\u7684\u8BCA\u65AD\u4EEA\u5668\u690D\u5165\u4EBA\u4F53\u5185\uFF0C\u53EF\u968F\u8840\u6DB2\u5728\u4F53\u5185\u8FD0\u884C\uFF0C\u5B9E\u65F6\u5C06\u4F53\u5185\u4FE1\u606F\u4F20\u9001\u5230\u4E8E\u4F53\u5916\u8BB0\u5F55\u88C5\u7F6E\u3002 \n* \u4F7F\u6CBB\u7597\u66F4\u6709\u6548\u5C06\u5E38\u89C4\u6CBB\u7597\u836F\u7269\uFF0C\u53EF\u63D0\u9AD8\u836F\u6548\u3001\u51CF\u5C11\u7528\u91CF\u3001\u964D\u4F4E\u526F\u4F5C\u7528\u3002\u8FD9\u5BF9\u4E8E\u6076\u6027\u80BF\u7624\u7684\u6CBB\u7597\uFF0C\u6709\u91CD\u8981\u4F5C\u7528\u3002 \n* \u6210\u4E3A\u9632\u75C5\u65B0\u6B66\u5668\u8FD0\u7528\u7EB3\u7C73\u6280\u672F\u5728\u8840\u6D41\u4E2D\u8FDB\u884C\u5DE1\u822A\u63A2\u6D4B\uFF0C\u53EF\u53CA\u65F6\u53D1\u73B0\u75C5\u6BD2\u3001\u7EC6\u83CC\u7684\u5165\u4FB5\uFF0C\u5E76\u4E88\u4EE5\u6B7C\u706D\uFF0C\u4ECE\u800C\u6D88\u9664\u4F20\u67D3\u75C5\u3002"@zh . . . . . . . . . . . "\u064A\u0645\u062B\u0644 \u0637\u0628 \u0627\u0644\u0646\u0627\u0646\u0648 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Nanomedicine)\u200F \u062A\u0644\u0643 \u0627\u0644\u062A\u0637\u0628\u064A\u0642\u0627\u062A \u0627\u0644\u0637\u0628\u064A\u0629 \u0644\u062A\u0642\u0646\u064A\u0629 \u0627\u0644\u0646\u0627\u0646\u0648. \u0648\u062A\u062A\u0646\u0648\u0639 \u0645\u062C\u0627\u0644\u0627\u062A \u0627\u0644\u0637\u0628 \u0627\u0644\u0646\u0627\u0646\u0648\u064A \u0645\u0646 \u0645\u062C\u0645\u0648\u0639\u0629 \u0627\u0644\u062A\u0637\u0628\u064A\u0642\u0627\u062A \u0627\u0644\u0637\u0628\u064A\u0629 \u0644\u0644\u0645\u0648\u0627\u062F \u0627\u0644\u0646\u0627\u0646\u0648\u064A\u0629\u060C \u0648\u0623\u062C\u0647\u0632\u0629 \u0627\u0644\u0627\u0633\u062A\u0634\u0639\u0627\u0631 \u0627\u0644\u0625\u0644\u0643\u062A\u0631\u0648\u0646\u064A\u0629 \u0627\u0644\u0646\u0627\u0646\u0648\u064A\u0629\u060C \u0625\u0644\u0649 \u0627\u0644\u062A\u0637\u0628\u064A\u0642\u0627\u062A \u0627\u0644\u0645\u0633\u062A\u0642\u0628\u0644\u064A\u0629 \u0627\u0644\u0645\u062A\u0627\u062D\u0629 . \u0625\u0644\u0627 \u0623\u0646 \u0627\u0644\u0645\u0634\u0643\u0644\u0627\u062A \u0627\u0644\u062D\u0627\u0644\u064A\u0629 \u0627\u0644\u062A\u064A \u062A\u0648\u0627\u062C\u0647 \u0627\u0644\u0637\u0628 \u0644\u0646\u0627\u0646\u0648\u064A \u0643\u062B\u064A\u0631\u0629\u060C \u062A\u0646\u0637\u0648\u064A \u0623\u0647\u0645\u0647\u0623\u0639\u0644\u0649 \u0641\u0647\u0645 \u0627\u0644\u0642\u0636\u0627\u064A\u0627 \u0627\u0644\u0645\u062A\u0635\u0644\u0629 \u0628\u0639\u0644\u0645 \u0627\u0644\u0633\u0645\u0648\u0645 \u0627\u0644\u0646\u0627\u0646\u0648\u064A \u0648\u0627\u0644\u0623\u062B\u0631 \u0627\u0644\u0628\u064A\u0626\u064A \u0644\u0644\u0645\u0648\u0627\u062F \u0627\u0644\u0646\u0627\u0646\u0648\u0645\u062A\u0631\u064A\u0629 \u0627\u0644\u062D\u062C\u0645."@ar . . "\u041D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u0301\u043D\u0430 \u2014 \u0446\u0435 \u043C\u0435\u0434\u0438\u0447\u043D\u0435 \u0437\u0430\u0441\u0442\u043E\u0441\u0443\u0432\u0430\u043D\u043D\u044F \u043D\u0430\u043D\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0456\u0457. \u0422\u0430\u043A \u0441\u0430\u043C\u043E, \u044F\u043A \u0456 \u0442\u0440\u0430\u0434\u0438\u0446\u0456\u0439\u043D\u0430 \u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0430, \u0432\u043E\u043D\u0430 \u0432\u043A\u043B\u044E\u0447\u0430\u0454 \u0432 \u0441\u0435\u0431\u0435 \u0434\u0456\u0430\u0433\u043D\u043E\u0441\u0442\u0438\u043A\u0443, \u043B\u0456\u043A\u0443\u0432\u0430\u043D\u043D\u044F \u0442\u0430 \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u043A\u0443 \u0445\u0432\u043E\u0440\u043E\u0431\u0438, \u0442\u0456\u043B\u044C\u043A\u0438 \u0432\u0441\u0435 \u0446\u0435 \u0432\u0438\u043A\u043E\u043D\u0443\u0454\u0442\u044C\u0441\u044F \u043C\u043E\u043B\u0435\u043A\u0443\u043B\u044F\u0440\u043D\u0438\u043C\u0438 \u0456\u043D\u0441\u0442\u0440\u0443\u043C\u0435\u043D\u0442\u0430\u043C\u0438. \u041F\u0435\u0440\u0435\u0445\u0456\u0434 \u0434\u043E \u043D\u0430\u043D\u043E\u0440\u043E\u0437\u043C\u0456\u0440\u0456\u0432 \u0432 \u043C\u0435\u0434\u0438\u0447\u043D\u043E\u043C\u0443 \u0456\u043D\u0441\u0442\u0440\u0443\u043C\u0435\u043D\u0442\u0430\u0440\u0456\u0457 \u043C\u0430\u0454 \u0446\u0456\u043B\u043A\u043E\u043C \u043B\u043E\u0433\u0456\u0447\u043D\u0435 \u043F\u043E\u044F\u0441\u043D\u0435\u043D\u043D\u044F. \u041E\u0441\u043D\u043E\u0432\u043D\u0438\u0439 \u043E\u0431'\u0454\u043A\u0442 \u0432\u043F\u043B\u0438\u0432\u0443 \u0441\u0443\u0447\u0430\u0441\u043D\u043E\u0457 \u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0438 \u2014 \u0446\u0435 \u043A\u043B\u0456\u0442\u0438\u043D\u0430, \u0430 \u0447\u0430\u0441\u0442\u043E \u2014 \u043C\u0430\u043A\u0440\u043E\u043C\u043E\u043B\u0435\u043A\u0443\u043B\u0438 (\u0414\u041D\u041A, \u0431\u0456\u043B\u043A\u0438, \u0440\u0456\u0434\u0448\u0435 \u043F\u043E\u043B\u0456\u0441\u0430\u0445\u0430\u0440\u0438\u0434\u0438). \u0410\u043B\u0435 \u044F\u043A\u0449\u043E \u0440\u043E\u0437\u043C\u0456\u0440 \u043A\u043B\u0456\u0442\u0438\u043D 7-20 \u043C\u043A\u043C, \u0430 \u0434\u0456\u0430\u043C\u0435\u0442\u0440 \u043F\u043E\u0434\u0432\u0456\u0439\u043D\u043E\u0457 \u0441\u043F\u0456\u0440\u0430\u043B\u0456 \u0414\u041D\u041A 2,4 \u043D\u043C, \u0442\u043E \u0439 \u0456\u043D\u0441\u0442\u0440\u0443\u043C\u0435\u043D\u0442\u0438 \u0434\u043B\u044F \u0457\u0445 \u043B\u0430\u0433\u043E\u0434\u0436\u0435\u043D\u043D\u044F \u043F\u043E\u0432\u0438\u043D\u043D\u0456 \u0431\u0443\u0442\u0438 \u0442\u043E\u0433\u043E \u0436 \u043F\u043E\u0440\u044F\u0434\u043A\u0443, \u0449\u043E \u0456 \u043E\u0431'\u0454\u043A\u0442, \u0442\u043E\u0431\u0442\u043E \u043D\u0430\u043D\u043E\u043C\u0435\u0442\u0440\u043E\u0432\u043E\u0433\u043E \u0434\u0456\u0430\u043F\u0430\u0437\u043E\u043D\u0443."@uk . . . "La nanomedicina \u00E9s la branca de la medicina que aplica els coneixements de la nanotecnologia a les ci\u00E8ncies i procediments m\u00E8dics. La nanomedicina compr\u00E8n des de les aplicacions m\u00E8diques dels nanomaterials fins als biosensors i, fins i tot, fins a possibles futures aplicacions de la . Els problemes actuals de la nanomedicina tenen a veure amb la comprensi\u00F3 de temes relacionats amb la i l'impacte ambiental de materials a nanoescala (materials l'estructura dels quals \u00E9s de l'escala de nan\u00F2metres, \u00E9s a dir, milmilion\u00E8simes parts de metre)."@ca . . . . "Nanoparticles ', liposomes ', and dendrimers are some nanomaterials being investigated for use in nanomedicine."@en . . . . . "La nanom\u00E9decine est l'application m\u00E9dicale de la nanotechnologie et de la recherche apparent\u00E9e. Elle couvre les domaines de l'administration de m\u00E9dicaments sous forme de nanoparticules et les possibles applications futures de la nanotechnologie mol\u00E9culaire (MNT)."@fr . . . "\u041D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0430 \u2014 \u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0441\u043A\u043E\u0435 \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u0435 \u043D\u0430\u043D\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0438\u0438. \u041F\u0440\u043E\u0441\u0442\u0438\u0440\u0430\u0435\u0442\u0441\u044F \u043E\u0442 \u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0441\u043A\u043E\u0433\u043E \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u044F \u043D\u0430\u043D\u043E\u043C\u0430\u0442\u0435\u0440\u0438\u0430\u043B\u043E\u0432 \u0434\u043E \u043D\u0430\u043D\u043E\u044D\u043B\u0435\u043A\u0442\u0440\u043E\u043D\u043D\u044B\u0445 \u0431\u0438\u043E\u0441\u0435\u043D\u0441\u043E\u0440\u043E\u0432 \u0438 \u0434\u0430\u0436\u0435 \u0432\u043E\u0437\u043C\u043E\u0436\u043D\u043E\u0433\u043E \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u044F \u043C\u043E\u043B\u0435\u043A\u0443\u043B\u044F\u0440\u043D\u043E\u0439 \u043D\u0430\u043D\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0438\u0438 \u0432 \u0431\u0443\u0434\u0443\u0449\u0435\u043C. \u041D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0441\u043A\u0438\u0435 \u0438\u0441\u0441\u043B\u0435\u0434\u043E\u0432\u0430\u043D\u0438\u044F \u0444\u0438\u043D\u0430\u043D\u0441\u0438\u0440\u0443\u044E\u0442\u0441\u044F \u0443\u043A\u0440\u0430\u0438\u043D\u0441\u043A\u0438\u043C . \u0418\u0437\u0432\u0435\u0441\u0442\u043D\u043E, \u0447\u0442\u043E \u0432 1914-\u043C \u0433\u043E\u0434\u0443 \u0432\u044B\u0434\u0435\u043B\u044F\u043B\u0438\u0441\u044C \u0434\u0435\u043D\u044C\u0433\u0438 \u043D\u0430 \u043F\u044F\u0442\u0438\u043B\u0435\u0442\u043D\u0438\u0439 \u043F\u043B\u0430\u043D \u043F\u043E \u043E\u0441\u043D\u043E\u0432\u0430\u043D\u0438\u044E \u0447\u0435\u0442\u044B\u0440\u0451\u0445 \u043D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0441\u043A\u0438\u0445 \u0446\u0435\u043D\u0442\u0440\u043E\u0432. \u0412 \u0430\u043F\u0440\u0435\u043B\u0435 2006, \u043F\u043E \u043E\u0446\u0435\u043D\u043A\u0435 \u0436\u0443\u0440\u043D\u0430\u043B\u0430 Nature Materials, \u0431\u044B\u043B\u043E \u0441\u043E\u0437\u0434\u0430\u043D\u043E \u043F\u043E\u0440\u044F\u0434\u043A\u0430 130 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432 \u0438 \u0441\u0440\u0435\u0434\u0441\u0442\u0432 \u0434\u043E\u0441\u0442\u0430\u0432\u043A\u0438 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432 \u043D\u0430 \u043E\u0441\u043D\u043E\u0432\u0435 \u043D\u0430\u043D\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0438\u0439."@ru . . "Liposome.jpg"@en . . . . . . . . "Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials (materials whose structure is on the scale of nanometers, i.e. billionths of a meter). Functionalities can be added to nanomaterials by interfacing them with biological molecules or structures. The size of nanomaterials is similar to that of most biological molecules and structures; therefore, nanomaterials can be useful for both in vivo and in vitro biomedical research and applications. Thus far, the integration of nanomaterials with biology has led to the development of diagnostic devices, contrast agents, analytical tools, physical therapy applications, and drug delivery vehicles. Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices in the near future. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced drug delivery systems, new therapies, and in vivo imaging. Nanomedicine research is receiving funding from the US National Institutes of Health Common Fund program, supporting four nanomedicine development centers. Nanomedicine sales reached $16 billion in 2015, with a minimum of $3.8 billion in nanotechnology R&D being invested every year. Global funding for emerging nanotechnology increased by 45% per year in recent years, with product sales exceeding $1 trillion in 2013. As the nanomedicine industry continues to grow, it is expected to have a significant impact on the economy."@en . . . "La nanomedicina es la aplicaci\u00F3n de la nanotecnolog\u00EDa en biomedicina, con el fin \u00FAltimo de mejorar la calidad de vida de los seres humanos, combatiendo las enfermedades de una forma innovadora.\u200B Un nan\u00F3metro (nm) es una millon\u00E9sima de un mil\u00EDmetro (10^-9 m). El aspecto m\u00E1s innovador de la nanomedicina es el empleo de nanomateriales para el diagn\u00F3stico y tratamiento de una patolog\u00EDa. La caracter\u00EDstica principal de un nanomaterial radica en que sus propiedades fisicoqu\u00EDmicas dependen del tama\u00F1o de dicho material.\u200B Mediante la modificaci\u00F3n del tama\u00F1o de dichos nanomateriales es posible obtener una se\u00F1al que nos indique la presencia o no de una enfermedad, entre otras muchas aplicaciones."@es . "Ilmu kedokteran nano (nanomedicine) adalah aplikasi medis dari teknologi nano. Istilah nanomedicine sendiri dapat berarti obat-obatan yang dibentuk dalam skala nano. Ilmu kedokteran nano mencakup aplikasi medis dari hingga biosensor nano. Satu pertentangan terhadap ilmu kedokteran nano yaitu mengenai toksisitas dan dampak lingkungan dari material nano."@in . "220"^^ . . . . . . . . "\u039D\u03B1\u03BD\u03BF\u03CA\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE"@el . . . . . . . . "Nanomedicina"@ca . . . "\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\uFF08\u82F1: nanomedicine\u3001\u307E\u305F\u306F\u30CA\u30CE\u533B\u7642\uFF09\u306F\u3001\u30CA\u30CE\u30C6\u30AF\u30CE\u30ED\u30B8\u30FC\u306E\u533B\u5B66\u7684\u5FDC\u7528\u3067\u3042\u308B\u3002\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\u306F\u3001\u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u3084\u751F\u4F53\u30C7\u30D0\u30A4\u30B9\u306E\u533B\u7642\u7528\u9014\u304B\u3089\u3001\u30CA\u30CE\u96FB\u5B50\u30D0\u30A4\u30AA\u30BB\u30F3\u30B5\u30FC\u3001\u3055\u3089\u306B\u306F\u5C06\u6765\u7684\u306B\u306F\u751F\u4F53\u5206\u5B50\u6A5F\u68B0\u306A\u3069\u306E\u5206\u5B50\u30CA\u30CE\u30C6\u30AF\u30CE\u30ED\u30B8\u30FC (\u82F1\u8A9E\u7248) \u306E\u5FDC\u7528\u306B\u307E\u3067\u53CA\u3093\u3067\u3044\u308B\u3002\u73FE\u5728\u306E\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\u306E\u8AB2\u984C\u306F\u3001\u30CA\u30CE\u30B9\u30B1\u30FC\u30EB\u306E\u6750\u6599\uFF08\u69CB\u9020\u304C\u30CA\u30CE\u30E1\u30FC\u30C8\u30EB\u306E\u30B9\u30B1\u30FC\u30EB\u3001\u3059\u306A\u308F\u306110\u5104\u5206\u306E1\u30E1\u30FC\u30C8\u30EB\u306E\u6750\u6599\uFF09\u306E\u3084\u74B0\u5883\u3078\u306E\u5F71\u97FF\u3092\u7406\u89E3\u3059\u308B\u3053\u3068\u306B\u3042\u308B\u3002 \u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u306B\u306F\u3001\u751F\u4F53\u5206\u5B50\u3084\u69CB\u9020\u7269\u3068\u76F8\u4E92\u4F5C\u7528\u3055\u305B\u308B\u3053\u3068\u3067\u6A5F\u80FD\u3092\u4ED8\u52A0\u3059\u308B\u3053\u3068\u304C\u3067\u304D\u308B\u3002\u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u306E\u30B5\u30A4\u30BA\u306F\u3001\u307B\u3068\u3093\u3069\u306E\u751F\u7269\u5B66\u7684\u5206\u5B50\u3084\u69CB\u9020\u4F53\u306E\u30B5\u30A4\u30BA\u306B\u4F3C\u3066\u3044\u308B\u305F\u3081\u3001\u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u306F\u3001\u751F\u4F53\u5185\uFF08in vivo\uFF09\u304A\u3088\u3073\u8A66\u9A13\u7BA1\u5185\uFF08in vitro\uFF09\u306E\u751F\u7269\u533B\u5B66\u7814\u7A76\u304A\u3088\u3073\u5FDC\u7528\u306E\u4E21\u65B9\u306B\u6709\u7528\u3067\u3042\u308B\u3002\u3053\u308C\u307E\u3067\u306E\u3068\u3053\u308D\u3001\u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u3068\u751F\u7269\u5B66\u306E\u878D\u5408\u306F\u3001\u8A3A\u65AD\u88C5\u7F6E\u3001\u9020\u5F71\u5264\u3001\u5206\u6790\u30C4\u30FC\u30EB\u3001\u7406\u5B66\u7642\u6CD5\u30A2\u30D7\u30EA\u30B1\u30FC\u30B7\u30E7\u30F3\u3001\u30C9\u30E9\u30C3\u30B0\u30C7\u30EA\u30D0\u30EA\u30FC\u30D3\u30FC\u30AF\u30EB\uFF08\u85AC\u7269\u9001\u9054\u62C5\u4F53\uFF09\u306E\u958B\u767A\u306B\u3064\u306A\u304C\u3063\u3066\u3044\u308B\u3002 \u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\u306F\u3001\u8FD1\u3044\u5C06\u6765\u3001\u5F79\u7ACB\u3064\u7814\u7A76\u30C4\u30FC\u30EB\u3068\u81E8\u5E8A\u7684\u306B\u6709\u7528\u306A\u30C7\u30D0\u30A4\u30B9\u306E\u4E00\u5F0F\u3092\u63D0\u4F9B\u3059\u308B\u3053\u3068\u3092\u76EE\u6307\u3057\u3066\u3044\u308B\u3002\u7C73\u56FD\u306B\u304A\u3044\u3066\u306F\u3001\u56FD\u5BB6\u30CA\u30CE\u30C6\u30AF\u30CE\u30ED\u30B8\u30FC\u30FB\u30A4\u30CB\u30B7\u30A2\u30C6\u30A3\u30D6\u3067\u3001\u9AD8\u5EA6\u306A\u30C9\u30E9\u30C3\u30B0\u30C7\u30EA\u30D0\u30EA\u30FC\u30B7\u30B9\u30C6\u30E0\u3001\u65B0\u3057\u3044\u6CBB\u7642\u6CD5\u3001in vivo\u30A4\u30E1\u30FC\u30B8\u30F3\u30B0\u306A\u3069\u3001\u88FD\u85AC\u696D\u754C\u306B\u304A\u3051\u308B\u65B0\u305F\u306A\u5546\u696D\u7684\u5FDC\u7528\u3092\u671F\u5F85\u3057\u3066\u3044\u308B\u3002\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\u7814\u7A76\u306F\u3001\u7C73\u56FD\u56FD\u7ACB\u885B\u751F\u7814\u7A76\u6240\u306E\u5171\u901A\u57FA\u91D1\u30D7\u30ED\u30B0\u30E9\u30E0\u304B\u3089\u8CC7\u91D1\u63F4\u52A9\u3092\u53D7\u3051\u3066\u30014\u3064\u306E\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\u958B\u767A\u30BB\u30F3\u30BF\u30FC\u3092\u30B5\u30DD\u30FC\u30C8\u3057\u3066\u3044\u308B\u3002 \u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\u306E\u58F2\u4E0A\u9AD8\u306F2015\u5E74\u306B160\u5104\u30C9\u30EB\u306B\u9054\u3057\u3001\u30CA\u30CE\u30C6\u30AF\u30CE\u30ED\u30B8\u30FC\u7814\u7A76\u958B\u767A\u306B\u6BCE\u5E74\u6700\u4F4E38\u5104\u30C9\u30EB\u304C\u6295\u8CC7\u3055\u308C\u3066\u3044\u308B\u3002\u65B0\u8208\u30CA\u30CE\u30C6\u30AF\u30CE\u30ED\u30B8\u30FC\u3078\u306E\u4E16\u754C\u7684\u306A\u8CC7\u91D1\u63D0\u4F9B\u306F\u3001\u3053\u3053\u6570\u5E74\u3067\u5E74\u738745\uFF05\u5897\u52A0\u3057\u30012013\u5E74\u306E\u88FD\u54C1\u58F2\u4E0A\u9AD8\u306F1\u5146\u30C9\u30EB\u3092\u8D85\u3048\u305F\u3002\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\u7523\u696D\u304C\u6210\u9577\u3092\u7D9A\u3051\u308B\u4E2D\u3067\u3001\u7D4C\u6E08\u306B\u5927\u304D\u306A\u5F71\u97FF\u3092\u4E0E\u3048\u308B\u3053\u3068\u304C\u671F\u5F85\u3055\u308C\u3066\u3044\u308B\u3002"@ja . . . . "\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\uFF08\u82F1: nanomedicine\u3001\u307E\u305F\u306F\u30CA\u30CE\u533B\u7642\uFF09\u306F\u3001\u30CA\u30CE\u30C6\u30AF\u30CE\u30ED\u30B8\u30FC\u306E\u533B\u5B66\u7684\u5FDC\u7528\u3067\u3042\u308B\u3002\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\u306F\u3001\u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u3084\u751F\u4F53\u30C7\u30D0\u30A4\u30B9\u306E\u533B\u7642\u7528\u9014\u304B\u3089\u3001\u30CA\u30CE\u96FB\u5B50\u30D0\u30A4\u30AA\u30BB\u30F3\u30B5\u30FC\u3001\u3055\u3089\u306B\u306F\u5C06\u6765\u7684\u306B\u306F\u751F\u4F53\u5206\u5B50\u6A5F\u68B0\u306A\u3069\u306E\u5206\u5B50\u30CA\u30CE\u30C6\u30AF\u30CE\u30ED\u30B8\u30FC (\u82F1\u8A9E\u7248) \u306E\u5FDC\u7528\u306B\u307E\u3067\u53CA\u3093\u3067\u3044\u308B\u3002\u73FE\u5728\u306E\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3\u306E\u8AB2\u984C\u306F\u3001\u30CA\u30CE\u30B9\u30B1\u30FC\u30EB\u306E\u6750\u6599\uFF08\u69CB\u9020\u304C\u30CA\u30CE\u30E1\u30FC\u30C8\u30EB\u306E\u30B9\u30B1\u30FC\u30EB\u3001\u3059\u306A\u308F\u306110\u5104\u5206\u306E1\u30E1\u30FC\u30C8\u30EB\u306E\u6750\u6599\uFF09\u306E\u3084\u74B0\u5883\u3078\u306E\u5F71\u97FF\u3092\u7406\u89E3\u3059\u308B\u3053\u3068\u306B\u3042\u308B\u3002 \u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u306B\u306F\u3001\u751F\u4F53\u5206\u5B50\u3084\u69CB\u9020\u7269\u3068\u76F8\u4E92\u4F5C\u7528\u3055\u305B\u308B\u3053\u3068\u3067\u6A5F\u80FD\u3092\u4ED8\u52A0\u3059\u308B\u3053\u3068\u304C\u3067\u304D\u308B\u3002\u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u306E\u30B5\u30A4\u30BA\u306F\u3001\u307B\u3068\u3093\u3069\u306E\u751F\u7269\u5B66\u7684\u5206\u5B50\u3084\u69CB\u9020\u4F53\u306E\u30B5\u30A4\u30BA\u306B\u4F3C\u3066\u3044\u308B\u305F\u3081\u3001\u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u306F\u3001\u751F\u4F53\u5185\uFF08in vivo\uFF09\u304A\u3088\u3073\u8A66\u9A13\u7BA1\u5185\uFF08in vitro\uFF09\u306E\u751F\u7269\u533B\u5B66\u7814\u7A76\u304A\u3088\u3073\u5FDC\u7528\u306E\u4E21\u65B9\u306B\u6709\u7528\u3067\u3042\u308B\u3002\u3053\u308C\u307E\u3067\u306E\u3068\u3053\u308D\u3001\u30CA\u30CE\u30DE\u30C6\u30EA\u30A2\u30EB\u3068\u751F\u7269\u5B66\u306E\u878D\u5408\u306F\u3001\u8A3A\u65AD\u88C5\u7F6E\u3001\u9020\u5F71\u5264\u3001\u5206\u6790\u30C4\u30FC\u30EB\u3001\u7406\u5B66\u7642\u6CD5\u30A2\u30D7\u30EA\u30B1\u30FC\u30B7\u30E7\u30F3\u3001\u30C9\u30E9\u30C3\u30B0\u30C7\u30EA\u30D0\u30EA\u30FC\u30D3\u30FC\u30AF\u30EB\uFF08\u85AC\u7269\u9001\u9054\u62C5\u4F53\uFF09\u306E\u958B\u767A\u306B\u3064\u306A\u304C\u3063\u3066\u3044\u308B\u3002"@ja . "\u064A\u0645\u062B\u0644 \u0637\u0628 \u0627\u0644\u0646\u0627\u0646\u0648 (\u0628\u0627\u0644\u0625\u0646\u062C\u0644\u064A\u0632\u064A\u0629: Nanomedicine)\u200F \u062A\u0644\u0643 \u0627\u0644\u062A\u0637\u0628\u064A\u0642\u0627\u062A \u0627\u0644\u0637\u0628\u064A\u0629 \u0644\u062A\u0642\u0646\u064A\u0629 \u0627\u0644\u0646\u0627\u0646\u0648. \u0648\u062A\u062A\u0646\u0648\u0639 \u0645\u062C\u0627\u0644\u0627\u062A \u0627\u0644\u0637\u0628 \u0627\u0644\u0646\u0627\u0646\u0648\u064A \u0645\u0646 \u0645\u062C\u0645\u0648\u0639\u0629 \u0627\u0644\u062A\u0637\u0628\u064A\u0642\u0627\u062A \u0627\u0644\u0637\u0628\u064A\u0629 \u0644\u0644\u0645\u0648\u0627\u062F \u0627\u0644\u0646\u0627\u0646\u0648\u064A\u0629\u060C \u0648\u0623\u062C\u0647\u0632\u0629 \u0627\u0644\u0627\u0633\u062A\u0634\u0639\u0627\u0631 \u0627\u0644\u0625\u0644\u0643\u062A\u0631\u0648\u0646\u064A\u0629 \u0627\u0644\u0646\u0627\u0646\u0648\u064A\u0629\u060C \u0625\u0644\u0649 \u0627\u0644\u062A\u0637\u0628\u064A\u0642\u0627\u062A \u0627\u0644\u0645\u0633\u062A\u0642\u0628\u0644\u064A\u0629 \u0627\u0644\u0645\u062A\u0627\u062D\u0629 . \u0625\u0644\u0627 \u0623\u0646 \u0627\u0644\u0645\u0634\u0643\u0644\u0627\u062A \u0627\u0644\u062D\u0627\u0644\u064A\u0629 \u0627\u0644\u062A\u064A \u062A\u0648\u0627\u062C\u0647 \u0627\u0644\u0637\u0628 \u0644\u0646\u0627\u0646\u0648\u064A \u0643\u062B\u064A\u0631\u0629\u060C \u062A\u0646\u0637\u0648\u064A \u0623\u0647\u0645\u0647\u0623\u0639\u0644\u0649 \u0641\u0647\u0645 \u0627\u0644\u0642\u0636\u0627\u064A\u0627 \u0627\u0644\u0645\u062A\u0635\u0644\u0629 \u0628\u0639\u0644\u0645 \u0627\u0644\u0633\u0645\u0648\u0645 \u0627\u0644\u0646\u0627\u0646\u0648\u064A \u0648\u0627\u0644\u0623\u062B\u0631 \u0627\u0644\u0628\u064A\u0626\u064A \u0644\u0644\u0645\u0648\u0627\u062F \u0627\u0644\u0646\u0627\u0646\u0648\u0645\u062A\u0631\u064A\u0629 \u0627\u0644\u062D\u062C\u0645. \u0648\u062A\u062A\u0644\u0642\u0649 \u0623\u0628\u062D\u0627\u062B \u0627\u0644\u0637\u0628 \u0627\u0644\u0646\u0627\u0646\u0648\u064A \u062A\u0645\u0648\u064A\u0644\u0627 \u0645\u0646 \u0645\u0639\u0627\u0647\u062F \u0627\u0644\u0635\u062D\u0629 \u0627\u0644\u0648\u0637\u0646\u064A\u0629 \u0627\u0644\u0623\u0645\u0631\u064A\u0643\u064A\u0629.\u0648\u062A\u062C\u062F\u0631 \u0627\u0644\u0625\u0634\u0627\u0631\u0629 \u0625\u0644\u0649 \u0623\u0646 \u062A\u0645\u0648\u064A\u0644 \u0627\u0644\u062E\u0637\u0629 \u0627\u0644\u062E\u0645\u0633\u064A\u0629 \u0641\u064A \u0639\u0627\u06452005 \u0627\u0633\u062A\u0647\u062F\u0641 \u0625\u0642\u0627\u0645\u0629 \u0623\u0631\u0628\u0639\u0629 \u0645\u0631\u0627\u0643\u0632 \u0644\u0637\u0628 \u0627\u0644\u0646\u0627\u0646\u0648. \u0648\u0641\u064A \u0623\u0628\u0631\u064A\u0644 2006\u060C \u0642\u062F\u0631\u062A \u0645\u062C\u0644\u0629 \u0623\u0646\u0647 \u0642\u062F \u062A\u0645 \u062A\u0646\u0645\u064A\u0629 \u0648\u062A\u0637\u0648\u064A\u0631 \u0646\u062D\u0648 130 \u062F\u0648\u0627\u0621 \u0642\u0627\u0626\u0645 \u0639\u0644\u0649 \u0627\u0644\u062A\u0642\u0627\u0646\u0629 \u0627\u0644\u0646\u0627\u0646\u0648\u064A\u0629 \u0628\u0627\u0644\u0625\u0636\u0627\u0641\u0629 \u0625\u0644\u0649 \u0623\u0646\u0638\u0645\u0629 \u062A\u0648\u0635\u064A\u0644 \u0627\u0644\u062F\u0648\u0627\u0621 \u0643\u0630\u0644\u0643 \u0639\u0628\u0631 \u0623\u0631\u062C\u0627\u0621 \u0627\u0644\u0639\u0627\u0644\u0645 \u0623\u062C\u0645\u0639."@ar . . . . "Nanomedicina"@pt . "43017"^^ . . "\u30CA\u30CE\u30E1\u30C7\u30A3\u30B7\u30F3"@ja . . "Nanomedikuntza"@eu . . . . "1110807427"^^ . . . . . "Nanomedizin"@de . "Nanom\u00E9decine"@fr . . "Ilmu kedokteran nano (nanomedicine) adalah aplikasi medis dari teknologi nano. Istilah nanomedicine sendiri dapat berarti obat-obatan yang dibentuk dalam skala nano. Ilmu kedokteran nano mencakup aplikasi medis dari hingga biosensor nano. Satu pertentangan terhadap ilmu kedokteran nano yaitu mengenai toksisitas dan dampak lingkungan dari material nano."@in . . . . . . . "A Nanotecnologia \u00E9 definida como: \"Design intencional, caracteriza\u00E7\u00E3o, produ\u00E7\u00E3o e aplica\u00E7\u00E3o de materiais, estruturas, aparelhos e sistemas controlando seu tamanho e formato na escala nanom\u00E9trica (1 a 100 nm)\". Este conceito aplicado \u00E0 medicina \u00E9 a \u00E1rea de trabalho da nanomedicina. Nanomateriais possuem semelhan\u00E7a com componentes de atividade biol\u00F3gica, prote\u00EDnas, bact\u00E9rias, c\u00E9lulas defeituosas e mol\u00E9culas, pois todos est\u00E3o contidos na escala nanom\u00E9trica. Dessa forma, h\u00E1 v\u00E1rias utilidades m\u00E9dicas para essa tecnologia, j\u00E1 que podem ser feitas para diferentes tamanhos e formatos dentro da escala, com composi\u00E7\u00F5es qu\u00EDmicas e propriedades de superf\u00EDcie diferentes. Atualmente \u00E9 utilizada para ve\u00EDculos de entrega de medicamentos, agentes de contraste, dispositivos de diagn\u00F3stico, do qual muitos est\u00E3o sob estudo ou j\u00E1 foram aprovados para uso em humanos pela FDA (Food and Drug Administration). Atualmente, j\u00E1 \u00E9 comum de muitos desses nanomateriais atuarem como ve\u00EDculos de entrega de medicamento em tumores, fazendo um tratamento localizado e espec\u00EDfico, diminuindo danos que poderiam ser ocasionados por outros tratamentos mais agressivos e menos espec\u00EDficos. Nanomateriais comuns que est\u00E3o em teste ou j\u00E1 foram aprovados pela FDA s\u00E3o: \u00F3xido de ferro (SPIONS), nanopart\u00EDculas de ouro, nanoshells, lipossomas, pol\u00EDmeros, dendr\u00EDmero e micela. Existem institui\u00E7\u00F5es como o Foresight Institute, fundada em 1986, que promove o desenvolvimento da nanotecnologia e outros tecnologias emergentes, sendo um deses focos de pesquisa a biotecnologia, visando a constru\u00E7\u00E3o desse conhecimento de forma segura e buscar formas de estender a expectativa de vida."@pt . . . . . "\u041D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0430"@uk . "Nanoparticles biomolecule interaction.svg"@en . . . "vertical"@en . . . . . . "\u7EB3\u7C73\u533B\u5B66\u662F\u968F\u7740\u7EB3\u7C73\u751F\u7269\u533B\u836F\u53D1\u5C55\u8D77\u6765\u7528\u7EB3\u7C73\u6280\u672F\u89E3\u51B3\u533B\u5B66\u95EE\u9898\u7684\u5B66\u79D1\u3002 \u7EB3\u7C73\u6280\u672F\u548C\u6750\u6599\u7684\u53D1\u5C55\u5C06\u5C06\u7ED9\u533B\u5B66\u9886\u57DF\u5E26\u6765\u4E00\u573A\u6DF1\u523B\u7684\u9769\u547D\uFF0C\u4E3B\u8981\u5728\u5BF9\u4ED8\u764C\u75C7\u548C\u6CBB\u7597\u5FC3\u8840\u7BA1\u75BE\u75C5\u65B9\u9762\u6709\u91CD\u8981\u610F\u4E49\u3002 \u7EB3\u7C73\u6750\u6599\u5177\u6709\u4E0E\u4E00\u822C\u6750\u6599\u6240\u4E0D\u540C\u7684\u7269\u7406\u5316\u5B66\u6027\u80FD\u3002 \u7EB3\u7C73\u6280\u672F\u53EF\u80FD\u5C06\u5728\u4EE5\u4E0B\u65B9\u9762\u5BF9\u533B\u5B66\u4EA7\u751F\u8F83\u5927\u7684\u5F71\u54CD\uFF1A \n* \u4F7F\u8BCA\u65AD\u66F4\u7CBE\u786E\u5E94\u7528\u7EB3\u7C73\u6280\u672F\u53EF\u5C06\u5FAE\u578B\u7684\u8BCA\u65AD\u4EEA\u5668\u690D\u5165\u4EBA\u4F53\u5185\uFF0C\u53EF\u968F\u8840\u6DB2\u5728\u4F53\u5185\u8FD0\u884C\uFF0C\u5B9E\u65F6\u5C06\u4F53\u5185\u4FE1\u606F\u4F20\u9001\u5230\u4E8E\u4F53\u5916\u8BB0\u5F55\u88C5\u7F6E\u3002 \n* \u4F7F\u6CBB\u7597\u66F4\u6709\u6548\u5C06\u5E38\u89C4\u6CBB\u7597\u836F\u7269\uFF0C\u53EF\u63D0\u9AD8\u836F\u6548\u3001\u51CF\u5C11\u7528\u91CF\u3001\u964D\u4F4E\u526F\u4F5C\u7528\u3002\u8FD9\u5BF9\u4E8E\u6076\u6027\u80BF\u7624\u7684\u6CBB\u7597\uFF0C\u6709\u91CD\u8981\u4F5C\u7528\u3002 \n* \u6210\u4E3A\u9632\u75C5\u65B0\u6B66\u5668\u8FD0\u7528\u7EB3\u7C73\u6280\u672F\u5728\u8840\u6D41\u4E2D\u8FDB\u884C\u5DE1\u822A\u63A2\u6D4B\uFF0C\u53EF\u53CA\u65F6\u53D1\u73B0\u75C5\u6BD2\u3001\u7EC6\u83CC\u7684\u5165\u4FB5\uFF0C\u5E76\u4E88\u4EE5\u6B7C\u706D\uFF0C\u4ECE\u800C\u6D88\u9664\u4F20\u67D3\u75C5\u3002"@zh . . . "Nanomedicine"@en . . . . . . . . . "Graphs.jpg"@en . . . . . "La nanomedicina \u00E9s la branca de la medicina que aplica els coneixements de la nanotecnologia a les ci\u00E8ncies i procediments m\u00E8dics. La nanomedicina compr\u00E8n des de les aplicacions m\u00E8diques dels nanomaterials fins als biosensors i, fins i tot, fins a possibles futures aplicacions de la . Els problemes actuals de la nanomedicina tenen a veure amb la comprensi\u00F3 de temes relacionats amb la i l'impacte ambiental de materials a nanoescala (materials l'estructura dels quals \u00E9s de l'escala de nan\u00F2metres, \u00E9s a dir, milmilion\u00E8simes parts de metre)."@ca . . . . . . . . . . . "Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials (materials whose structure is on the scale of nanometers, i.e. billionths of a meter)."@en . . . . . . . . . "\uB098\uB178\uC758\uD559\uC740 \uB098\uB178\uAE30\uC220\uC744 \uC758\uD559\uC801\uC73C\uB85C \uC751\uC6A9\uD55C \uD559\uBB38\uC774\uB77C\uACE0 \uD560 \uC218 \uC788\uB2E4. \uC774\uB294 \uB098\uB178\uBB3C\uC9C8\uC744 \uC758\uD559\uC801\uC73C\uB85C \uC751\uC6A9\uD55C \uAC83\uC5D0\uC11C\uBD80\uD130 \uB098\uB178 \uC804\uC790 \uC0DD\uCCB4\uC13C\uC11C, \uBBF8\uB798 \uAC00\uB2A5\uD55C \uBD84\uC790 \uB098\uB178\uAE30\uC220\uC744 \uC751\uC6A9\uD55C \uAC83\uAE4C\uC9C0 \uD3EC\uD568\uD55C\uB2E4. \uD604\uC7AC \uC774\uC640 \uAD00\uB828\uD574\uC11C \uAC00\uC7A5 \uD070 \uBB38\uC81C\uC810\uC73C\uB85C \uC5EC\uACA8\uC9C0\uB294 \uAC83\uC740 \uB098\uB178\uB2E8\uC704\uC758 \uBB3C\uC9C8\uB4E4\uC774 \uD658\uACBD\uACFC \uC778\uCCB4\uC5D0 \uC720\uB3C5\uD55C \uC601\uD5A5\uC744 \uB07C\uCE60 \uC218 \uC788\uB2E4\uB294 \uAC83\uC774\uB2E4. \uC0DD\uBB3C \uBD84\uC790\uB098 \uAD6C\uC870\uB97C \uB098\uB178 \uBB3C\uC9C8\uACFC \uC811\uBAA9\uC2DC\uD0B4\uC73C\uB85C\uC368 \uC5EC\uB7EC \uB2E4\uC591\uD55C \uAE30\uB2A5\uB4E4\uC744 \uAC00\uC9C0\uAC8C \uD560 \uC218 \uC788\uB294\uB370, \uB098\uB178 \uBB3C\uC9C8\uB4E4\uC758 \uD06C\uAE30\uAC00 \uB300\uBD80\uBD84\uC758 \uC0DD\uBB3C\uD559\uC801\uC778 \uBD84\uC790\uB098 \uAD6C\uC870\uC758 \uD06C\uAE30\uC640 \uBE44\uC2B7\uD558\uAE30 \uB54C\uBB38\uC774\uB2E4. \uADF8\uB798\uC11C \uC774\uB294 \uCCB4\uB0B4, \uCCB4\uC678\uC758 \uC0DD\uBB3C\uC758\uD559 \uC5F0\uAD6C, \uC751\uC6A9\uC5D0 \uB9E4\uC6B0 \uC720\uC6A9\uD558\uB2E4. \uC9C0\uAE08\uAE4C\uC9C0\uB294 \uB098\uB178 \uBB3C\uC9C8\uB4E4\uC774 \uC0DD\uBB3C\uD559\uACFC \uACB0\uD569\uD574\uC11C \uC9C4\uB2E8 \uAE30\uAE30, \uC0DD\uCCB4 \uBD84\uC11D\uAE30\uAD6C, \uBB3C\uB9AC\uCE58\uB8CC \uC694\uBC95, \uC57D\uBB3C \uC804\uB2EC \uB9E4\uCCB4 \uB4F1\uC758 \uBC1C\uC804\uC774 \uC774\uB8E8\uC5B4\uC84C\uB2E4. \uB098\uB178\uBD07\uC744 \uBE44\uB86F\uD574\uCE58\uB8CC\uD558\uACE0 \uC2E0\uCCB4\uC801 \uAE30\uB2A5\uC744 \uB354 \uB6F0\uC5B4\uB098\uAC8C \uB9CC\uB4E4\uC5B4 \uC904 \uC218 \uC788\uC73C\uBA70, \uB354 \uB098\uC544\uAC00 \uC815\uC2E0\uC801\uC778 \uBD80\uBD84\uAE4C\uC9C0 \uC774\uC810\uC744 \uAC00\uC838\uB2E4\uC904 \uAC83\uC774\uB2E4."@ko . . "\u041D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0430 \u2014 \u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0441\u043A\u043E\u0435 \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u0435 \u043D\u0430\u043D\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0438\u0438. \u041F\u0440\u043E\u0441\u0442\u0438\u0440\u0430\u0435\u0442\u0441\u044F \u043E\u0442 \u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0441\u043A\u043E\u0433\u043E \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u044F \u043D\u0430\u043D\u043E\u043C\u0430\u0442\u0435\u0440\u0438\u0430\u043B\u043E\u0432 \u0434\u043E \u043D\u0430\u043D\u043E\u044D\u043B\u0435\u043A\u0442\u0440\u043E\u043D\u043D\u044B\u0445 \u0431\u0438\u043E\u0441\u0435\u043D\u0441\u043E\u0440\u043E\u0432 \u0438 \u0434\u0430\u0436\u0435 \u0432\u043E\u0437\u043C\u043E\u0436\u043D\u043E\u0433\u043E \u043F\u0440\u0438\u043C\u0435\u043D\u0435\u043D\u0438\u044F \u043C\u043E\u043B\u0435\u043A\u0443\u043B\u044F\u0440\u043D\u043E\u0439 \u043D\u0430\u043D\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0438\u0438 \u0432 \u0431\u0443\u0434\u0443\u0449\u0435\u043C. \u041D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0441\u043A\u0438\u0435 \u0438\u0441\u0441\u043B\u0435\u0434\u043E\u0432\u0430\u043D\u0438\u044F \u0444\u0438\u043D\u0430\u043D\u0441\u0438\u0440\u0443\u044E\u0442\u0441\u044F \u0443\u043A\u0440\u0430\u0438\u043D\u0441\u043A\u0438\u043C . \u0418\u0437\u0432\u0435\u0441\u0442\u043D\u043E, \u0447\u0442\u043E \u0432 1914-\u043C \u0433\u043E\u0434\u0443 \u0432\u044B\u0434\u0435\u043B\u044F\u043B\u0438\u0441\u044C \u0434\u0435\u043D\u044C\u0433\u0438 \u043D\u0430 \u043F\u044F\u0442\u0438\u043B\u0435\u0442\u043D\u0438\u0439 \u043F\u043B\u0430\u043D \u043F\u043E \u043E\u0441\u043D\u043E\u0432\u0430\u043D\u0438\u044E \u0447\u0435\u0442\u044B\u0440\u0451\u0445 \u043D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0441\u043A\u0438\u0445 \u0446\u0435\u043D\u0442\u0440\u043E\u0432. \u0412 \u0430\u043F\u0440\u0435\u043B\u0435 2006, \u043F\u043E \u043E\u0446\u0435\u043D\u043A\u0435 \u0436\u0443\u0440\u043D\u0430\u043B\u0430 Nature Materials, \u0431\u044B\u043B\u043E \u0441\u043E\u0437\u0434\u0430\u043D\u043E \u043F\u043E\u0440\u044F\u0434\u043A\u0430 130 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432 \u0438 \u0441\u0440\u0435\u0434\u0441\u0442\u0432 \u0434\u043E\u0441\u0442\u0430\u0432\u043A\u0438 \u043B\u0435\u043A\u0430\u0440\u0441\u0442\u0432 \u043D\u0430 \u043E\u0441\u043D\u043E\u0432\u0435 \u043D\u0430\u043D\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0438\u0439."@ru . . . . . . "\u0397 \u03BD\u03B1\u03BD\u03BF\u03CA\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03B5\u03AF\u03BD\u03B1\u03B9 \u03B7 \u03B9\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03B5\u03C6\u03B1\u03C1\u03BC\u03BF\u03B3\u03AE \u03C4\u03B7\u03C2 \u03BD\u03B1\u03BD\u03BF\u03C4\u03B5\u03C7\u03BD\u03BF\u03BB\u03BF\u03B3\u03AF\u03B1\u03C2 . \u0397 \u03BD\u03B1\u03BD\u03BF\u03CA\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03B5\u03BA\u03C4\u03B5\u03AF\u03BD\u03B5\u03C4\u03B1\u03B9 \u03B1\u03C0\u03CC \u03C4\u03B9\u03C2 \u03B9\u03B1\u03C4\u03C1\u03B9\u03BA\u03AD\u03C2 \u03B5\u03C6\u03B1\u03C1\u03BC\u03BF\u03B3\u03AD\u03C2 \u03BD\u03B1\u03BD\u03BF\u03CB\u03BB\u03B9\u03BA\u03CE\u03BD \u03BA\u03B1\u03B9 \u03B2\u03B9\u03BF\u03BB\u03BF\u03B3\u03B9\u03BA\u03CE\u03BD \u03C3\u03C5\u03C3\u03BA\u03B5\u03C5\u03CE\u03BD, \u03AD\u03C9\u03C2 \u03C4\u03BF\u03C5\u03C2 \u03BD\u03B1\u03BD\u03BF\u03B7\u03BB\u03B5\u03BA\u03C4\u03C1\u03BF\u03BD\u03B9\u03BA\u03BF\u03CD\u03C2 \u03B2\u03B9\u03BF\u03B1\u03B9\u03C3\u03B8\u03B7\u03C4\u03AE\u03C1\u03B5\u03C2, \u03B1\u03BA\u03CC\u03BC\u03B7 \u03BA\u03B1\u03B9 \u03C0\u03B9\u03B8\u03B1\u03BD\u03AD\u03C2 \u03BC\u03B5\u03BB\u03BB\u03BF\u03BD\u03C4\u03B9\u03BA\u03AD\u03C2 \u03B5\u03C6\u03B1\u03C1\u03BC\u03BF\u03B3\u03AD\u03C2 \u03C4\u03B7\u03C2 \u03BC\u03BF\u03C1\u03B9\u03B1\u03BA\u03AE\u03C2 \u03BD\u03B1\u03BD\u03BF\u03C4\u03B5\u03C7\u03BD\u03BF\u03BB\u03BF\u03B3\u03AF\u03B1\u03C2, \u03CC\u03C0\u03C9\u03C2 \u03BF\u03B9 \u03B2\u03B9\u03BF\u03BB\u03BF\u03B3\u03B9\u03BA\u03AD\u03C2 \u03BC\u03B7\u03C7\u03B1\u03BD\u03AD\u03C2 . \u03A4\u03B1 \u03C4\u03C1\u03AD\u03C7\u03BF\u03BD\u03C4\u03B1 \u03C0\u03C1\u03BF\u03B2\u03BB\u03AE\u03BC\u03B1\u03C4\u03B1 \u03B3\u03B9\u03B1 \u03C4\u03B7 \u03BD\u03B1\u03BD\u03BF\u03CA\u03B1\u03C4\u03C1\u03B9\u03BA\u03AE \u03C0\u03B5\u03C1\u03B9\u03BB\u03B1\u03BC\u03B2\u03AC\u03BD\u03BF\u03C5\u03BD \u03C4\u03B7\u03BD \u03BA\u03B1\u03C4\u03B1\u03BD\u03CC\u03B7\u03C3\u03B7 \u03C4\u03C9\u03BD \u03B8\u03B5\u03BC\u03AC\u03C4\u03C9\u03BD \u03C0\u03BF\u03C5 \u03C3\u03C7\u03B5\u03C4\u03AF\u03B6\u03BF\u03BD\u03C4\u03B1\u03B9 \u03BC\u03B5 \u03C4\u03B7\u03BD \u03C4\u03BF\u03BE\u03B9\u03BA\u03CC\u03C4\u03B7\u03C4\u03B1 \u03BA\u03B1\u03B8\u03CE\u03C2 \u03BA\u03B1\u03B9 \u03C4\u03B9\u03C2 \u03C0\u03B5\u03C1\u03B9\u03B2\u03B1\u03BB\u03BB\u03BF\u03BD\u03C4\u03B9\u03BA\u03AD\u03C2 \u03B5\u03C0\u03B9\u03C0\u03C4\u03CE\u03C3\u03B5\u03B9\u03C2 \u03C4\u03C9\u03BD \u03C5\u03BB\u03B9\u03BA\u03CE\u03BD \u03BD\u03B1\u03BD\u03BF\u03BA\u03BB\u03AF\u03BC\u03B1\u03BA\u03B1\u03C2 (\u03C5\u03BB\u03B9\u03BA\u03CE\u03BD \u03C4\u03C9\u03BD \u03BF\u03C0\u03BF\u03AF\u03C9\u03BD \u03B7 \u03B4\u03BF\u03BC\u03AE \u03B5\u03AF\u03BD\u03B1\u03B9 \u03C3\u03C4\u03B7\u03BD \u03BA\u03BB\u03AF\u03BC\u03B1\u03BA\u03B1 \u03C4\u03C9\u03BD \u03BD\u03B1\u03BD\u03BF\u03BC\u03AD\u03C4\u03C1\u03C9\u03BD, \u03B4\u03B7\u03BB\u03B1\u03B4\u03AE \u03B4\u03B9\u03C3\u03B5\u03BA\u03B1\u03C4\u03BF\u03BC\u03BC\u03C5\u03C1\u03B9\u03BF\u03C3\u03C4\u03AC \u03C4\u03BF\u03C5 \u03BC\u03AD\u03C4\u03C1\u03BF\u03C5 )."@el . . . . "\uB098\uB178\uC758\uD559"@ko . . . . . "La nanom\u00E9decine est l'application m\u00E9dicale de la nanotechnologie et de la recherche apparent\u00E9e. Elle couvre les domaines de l'administration de m\u00E9dicaments sous forme de nanoparticules et les possibles applications futures de la nanotechnologie mol\u00E9culaire (MNT)."@fr . . . . "\u041D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u0301\u043D\u0430 \u2014 \u0446\u0435 \u043C\u0435\u0434\u0438\u0447\u043D\u0435 \u0437\u0430\u0441\u0442\u043E\u0441\u0443\u0432\u0430\u043D\u043D\u044F \u043D\u0430\u043D\u043E\u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0456\u0457. \u0422\u0430\u043A \u0441\u0430\u043C\u043E, \u044F\u043A \u0456 \u0442\u0440\u0430\u0434\u0438\u0446\u0456\u0439\u043D\u0430 \u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0430, \u0432\u043E\u043D\u0430 \u0432\u043A\u043B\u044E\u0447\u0430\u0454 \u0432 \u0441\u0435\u0431\u0435 \u0434\u0456\u0430\u0433\u043D\u043E\u0441\u0442\u0438\u043A\u0443, \u043B\u0456\u043A\u0443\u0432\u0430\u043D\u043D\u044F \u0442\u0430 \u043F\u0440\u043E\u0444\u0456\u043B\u0430\u043A\u0442\u0438\u043A\u0443 \u0445\u0432\u043E\u0440\u043E\u0431\u0438, \u0442\u0456\u043B\u044C\u043A\u0438 \u0432\u0441\u0435 \u0446\u0435 \u0432\u0438\u043A\u043E\u043D\u0443\u0454\u0442\u044C\u0441\u044F \u043C\u043E\u043B\u0435\u043A\u0443\u043B\u044F\u0440\u043D\u0438\u043C\u0438 \u0456\u043D\u0441\u0442\u0440\u0443\u043C\u0435\u043D\u0442\u0430\u043C\u0438. \u041F\u0435\u0440\u0435\u0445\u0456\u0434 \u0434\u043E \u043D\u0430\u043D\u043E\u0440\u043E\u0437\u043C\u0456\u0440\u0456\u0432 \u0432 \u043C\u0435\u0434\u0438\u0447\u043D\u043E\u043C\u0443 \u0456\u043D\u0441\u0442\u0440\u0443\u043C\u0435\u043D\u0442\u0430\u0440\u0456\u0457 \u043C\u0430\u0454 \u0446\u0456\u043B\u043A\u043E\u043C \u043B\u043E\u0433\u0456\u0447\u043D\u0435 \u043F\u043E\u044F\u0441\u043D\u0435\u043D\u043D\u044F. \u041E\u0441\u043D\u043E\u0432\u043D\u0438\u0439 \u043E\u0431'\u0454\u043A\u0442 \u0432\u043F\u043B\u0438\u0432\u0443 \u0441\u0443\u0447\u0430\u0441\u043D\u043E\u0457 \u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0438 \u2014 \u0446\u0435 \u043A\u043B\u0456\u0442\u0438\u043D\u0430, \u0430 \u0447\u0430\u0441\u0442\u043E \u2014 \u043C\u0430\u043A\u0440\u043E\u043C\u043E\u043B\u0435\u043A\u0443\u043B\u0438 (\u0414\u041D\u041A, \u0431\u0456\u043B\u043A\u0438, \u0440\u0456\u0434\u0448\u0435 \u043F\u043E\u043B\u0456\u0441\u0430\u0445\u0430\u0440\u0438\u0434\u0438). \u0410\u043B\u0435 \u044F\u043A\u0449\u043E \u0440\u043E\u0437\u043C\u0456\u0440 \u043A\u043B\u0456\u0442\u0438\u043D 7-20 \u043C\u043A\u043C, \u0430 \u0434\u0456\u0430\u043C\u0435\u0442\u0440 \u043F\u043E\u0434\u0432\u0456\u0439\u043D\u043E\u0457 \u0441\u043F\u0456\u0440\u0430\u043B\u0456 \u0414\u041D\u041A 2,4 \u043D\u043C, \u0442\u043E \u0439 \u0456\u043D\u0441\u0442\u0440\u0443\u043C\u0435\u043D\u0442\u0438 \u0434\u043B\u044F \u0457\u0445 \u043B\u0430\u0433\u043E\u0434\u0436\u0435\u043D\u043D\u044F \u043F\u043E\u0432\u0438\u043D\u043D\u0456 \u0431\u0443\u0442\u0438 \u0442\u043E\u0433\u043E \u0436 \u043F\u043E\u0440\u044F\u0434\u043A\u0443, \u0449\u043E \u0456 \u043E\u0431'\u0454\u043A\u0442, \u0442\u043E\u0431\u0442\u043E \u043D\u0430\u043D\u043E\u043C\u0435\u0442\u0440\u043E\u0432\u043E\u0433\u043E \u0434\u0456\u0430\u043F\u0430\u0437\u043E\u043D\u0443. \u0423 2021 \u0440\u043E\u0446\u0456 \u043E\u0431\u0441\u044F\u0433 \u0441\u0432\u0456\u0442\u043E\u0432\u043E\u0433\u043E \u0440\u0438\u043D\u043A\u0443 \u043D\u0430\u043D\u043E\u043C\u0435\u0434\u0438\u0446\u0438\u043D\u0438 \u043E\u0446\u0456\u043D\u044E\u0432\u0430\u0432\u0441\u044F \u0432 159,53 \u043C\u0456\u043B\u044C\u044F\u0440\u0434\u0430 \u0434\u043E\u043B\u0430\u0440\u0456\u0432 \u0421\u0428\u0410, \u0456 \u043E\u0447\u0456\u043A\u0443\u0454\u0442\u044C\u0441\u044F, \u0449\u043E \u0437 2022 \u043F\u043E 2030 \u0440\u0456\u043A \u0432\u0456\u043D \u0437\u0440\u043E\u0441\u0442\u0430\u0442\u0438\u043C\u0435 \u043D\u0430 11,7% \u0443 \u0441\u0435\u0440\u0435\u0434\u043D\u044C\u043E\u0440\u0456\u0447\u043D\u043E\u043C\u0443 \u0442\u0435\u043C\u043F\u0456 \u0437\u0440\u043E\u0441\u0442\u0430\u043D\u043D\u044F."@uk . . . "Nanomedikuntza nanoteknologiaren zati bat da, gaixotasunak gorputzaren barnetik sendatzea ahalbidetzen duen maila zelular eta molekular batean. Medikuntzaren barnean dauden aurrerapenen artean arrakastatsuenetakoa da.Osasun eremuan nanoteknologia aplikatzea biziki baliagarria gerta daiteke, diagnostiko zehatzagoak egiteko edo terapia eraginkorragoak eragiteko, botika premiazkoa den toki zehatzera joan dadin (horrek, noski, alboko efektuak murriztu egingo lituzke) edo zelulekin komunikatzeko gauza liratekeen materialak sortzeko, ehunen birsorkuntza eragin dezaten, adibidez."@eu . . . . "Ilmu kedokteran nano"@in . . . . .